At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Carnosinedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients
In Brief
A clinical study evaluating Carnosine for Diabetic Neuropathies. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Evaluation of the influence of oral administration of carnosine in combination with vitamin B Complex in preventing the progression of diabetic neuropathy in type 2 diabetes patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Neuropathies
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJan 2021
Primary CompletionJan 2022
Study CompletionMar 2022
First PostedJun 2022
TodayJul 2026
First PostedJun 16, 2022
Enrollment StartJan 14, 2021
Primary CompletionJan 30, 2022
Study CompletionMar 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.0 years ago
Interventions
Carnosinedietary
Patients who will receive carnosine supplementation 500mg capsules (Now foods) in combination with Vitamin B complex (B1+B6+B12, 150 mg+100 mg+1 mg, respectively, Neurovit, European Egyptian Pharm. Ind., Egypt), two tablets per day